Clinical trial
ESCAPE Migraine Trial
NCT00267371 · Abbott Medical Devices, Industry · Terminated
Key facts
| NCT number | NCT00267371 |
|---|---|
| Title | ESCAPE Migraine Trial |
| Official title | Effect of Septal Closure of Atrial PFO on Events of Migraine With Premere: ESCAPE Migraine Trial |
| Lead sponsor | Abbott Medical Devices, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Migraine Disorders, Heart Septal Defects, Atrial |
| Intervention type | Device, Drug |
| Interventions | PFO Closure with Premere investigational device., Medical management/current medications per standard of care by personal physician. |
| Enrollment | 168 |
| Start date | Nov 1, 2005 |
| Primary completion | Mar 1, 2012 |
| Completion | Mar 1, 2012 |
| First posted | Dec 20, 2005 |
| Last update posted | Feb 4, 2019 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: